The SARS-CoV-2 multibasic cleavage site facilitates early serine protease-mediated entry into organoid-derived human airway cells

Anna Z Mykytyn; Tim I Breugem; Samra Riesebosch; Debby Schipper; Petra B van den Doel; Robbert Rottier; Mart M Lamers; Bart L Haagmans.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-286120

Documentos relacionados

  1. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site.
  2. Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic.
  3. Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks.
  4. Urogenital System Damaging Manifestations of 3 Human Infected Coronaviruses.
  5. SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.
  6. The emergence of Covid-19: evolution from endemic to pandemic.
  7. Genome-Wide B Cell, CD4<sup>+</sup>, and CD8<sup>+</sup> T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines.
  8. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
  9. Neurological manifestations of coronavirus infections: role of angiotensin-converting enzyme 2 in COVID-19.
  10. Cell entry mechanisms of SARS-CoV-2.